Table 9.8b

Adjusted Graft Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 679 87.9% 1.3% 679 82.1% 1.5% 1,586 73.2% 1.2% 1,928 69.2% 1.3%
Primary Diagnosis Non-Cholestatic Cirrhosis 337 89.0% 1.9% 337 81.4% 2.5% 798 73.2% 1.9% 915 69.7% 2.2%
Cholestatic Liver Disease/Cirrhosis 137 90.7% 2.6% 137 87.6% 3.0% 285 78.0% 2.8% 315 72.8% 3.4%
Acute Hepatic Necrosis 35 78.4% 7.1% 35 73.3% 7.9% 84 66.0% 5.6% 114 65.3% 5.0%
Biliary Atresia 72 92.0% 3.4% 72 91.0% 3.7% 170 79.1% 4.3% 258 73.0% 4.3%
Metabolic Diseases 15 82.9% 8.9% 15 71.3% 11.0% 47 63.6% 7.4% 65 61.8% 6.7%
Malignant Neoplasms 28 78.8% 7.6% 28 60.9% 9.2% 85 58.5% 5.5% 109 51.6% 5.3%
Other 54 83.6% 5.0% 54 80.2% 5.5% 116 76.7% 4.4% 151 70.1% 4.7%
Unknown 1 0.0% 0.0% 1 0.0% 0.0% 1 0.0% 0.0% 1 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.